Clinical Trials Directory

Trials / Unknown

UnknownNCT02519920

Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the Skin

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
63 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study was to test an appropriate dose of fluorescein sodium which can provide high image quality to ensure endoscopy examination and have no yellow dye in the skin by a randomized blinded controlled trial.

Detailed description

Fluorescein sodium is one of the commonly used staining agents in confocal laser endoscopy, a device for in vivo real-time histological observation of the gastrointestinal mucosa. The conventional intravenous dosage of fluorescein sodium is in the range of 5ml to 10ml of 10% fluorescein. Image quality can be guaranteed with this range of fluorescein sodium, but yellow discoloration of the skin seriously influences daily life. This study was to test whether a lower dose of fluorescein sodium, which has minimal discoloration of skin, can provide satisfied image quality by a randomized blinded controlled trial.

Conditions

Interventions

TypeNameDescription
DRUGfluorescein sodium 0.01ml/kgfluorescein Sodium Dose of 0.01ml/kg on confocal laser endoscopy image quality and yellow discoloration of the skin
DRUGfluorescein sodium 0.02ml/kgfluorescein Sodium Dose of 0.02ml/kg on confocal laser endoscopy image quality and yellow discoloration of the skin
DRUGfluorescein sodium 0.05ml/kgfluorescein Sodium Dose of 0.05ml/kg on confocal laser endoscopy image quality and yellow discoloration of the skin
DRUGfluorescein sodium 0.1ml/kgfluorescein Sodium Dose of 0.1ml/kg on confocal laser endoscopy image quality and yellow discoloration of the skin

Timeline

Start date
2015-04-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-08-11
Last updated
2015-10-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02519920. Inclusion in this directory is not an endorsement.